Hou et al. reported that gynecological MM has unique molecular features compared to non-gynecological melanoma [26], and that programmed cell death ligand 1 (PD-L1) (56%) and programmed cell death (PD-1) (75%) were frequently expressed in gynecological MM [26]. This evidence concerns the gene CD274 and Miyoshi myopathy.